Dr. Zhang is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
525 E 68th St
# 141
New York, NY 10065Phone+1 212-746-6000Fax+1 646-962-0122
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Nuclear Medicine, 2013 - 2014
- New York Presbyterian Hospital (Cornell Campus)Residency, Nuclear Medicine, 2011 - 2012
- Shandong Medical UniversityClass of 1998
Certifications & Licensure
- NY State Medical License 2015 - 2026
- NJ State Medical License 2019 - 2025
- American Board of Nuclear Medicine Nuclear Medicine
- American Board of Radiology Diagnostic Radiology
Publications & Presentations
PubMed
- Results From First-in-Human Phase I Study of a Novel CD19-1XX Chimeric Antigen Receptor With Calibrated Signaling in Large B-Cell Lymphoma.Jae H Park, M Lia Palomba, Karlo Perica, Sean M Devlin, Gunjan Shah
Journal of Clinical Oncology. 2025-01-30 - 3 citationsZanubrutinib, obinutuzumab, and venetoclax for first-line treatment of mantle cell lymphoma with a TP53 mutation.Anita Kumar, Jacob Soumerai, Jeremy S Abramson, Jeffrey A Barnes, Philip Caron
Blood. 2025-01-30 - Calibrated CAR Signaling Enables Low-Dose Therapy in Large B-Cell Lymphoma.Jae Park, M Lia Palomba, Karlo Perica, Sean Devlin, Gunjan Shah
Research Square. 2024-07-02
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: